Oral Insulin: Next Steps
Pursue development with a formulated tablet vs. capsule
- Data from prototype to be announced at 3rd Annual Diabetes Technology Meeting 11/6/03-11/8/03 in San Francisco
Secure partner to expedite design and execution of development work
- Tablet dosage forms developed to allow for convenient pre-mealtime dosing
- Conducting cost-effective but commercially relevant studies; enhancing safety database
Multi-dose study (Germany)
- Single-center, double-blind, randomized, controlled, parallel-group study in diet-controlled Type 2 diabetic patients
- Screening, treatment and follow up phase to assess safety and efficacy
- Dose based on tablet prototype study